Analyst. PhD, protein folding. Co-founder, Clear Capital (acqd). Runs Aleth - open access research. Runner. Scot. Building world-class innovative companies.
@AnthropicAI This is a scary read. As a bioscientist with average AI abilities, I'm growing more worried about this bio weapons outcome specifically as its far too accessible to too many potential bad actors.
BREAKING NEWS
The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Chemistry with one half to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.”
7/ … there are obviously a whole host of reasons as to why we have reached this point. The markets are mirroring some of the general underlying problems that the UK is currently suffering from. Regardless, it is a time for urgent reform and action. #LSE#AIM $etx
BREAKING NEWS:
The 2021 #NobelPrize in Physiology or Medicine has been awarded jointly to David Julius and Ardem Patapoutian “for their discoveries of receptors for temperature and touch.”
Delighted to welcome Dr Ceri Morgan as Head of Late Stage Portfolio to the OSI team! 🥳
We spoke to Ceri to find out what attracted her to Oxford, why she has taken on the role of Head of Late Stage Portfolio and her ambitions!
Read more ➡️
https://t.co/Pewv441bwA
Today with @emblebi, we're launching the #AlphaFold Protein Structure Database, which offers the most complete and accurate picture of the human proteome, doubling humanity’s accumulated knowledge of high-accuracy human protein structures - for free: https://t.co/vtBGmTkKhy 1/
Today we celebrated our virtual @Nasdaq opening bell ringing. We are so proud of everything our team has accomplished together and we are committed to making a difference for patients. #BIGAxis
Today we celebrated our virtual @Nasdaq opening bell ringing. We are so proud of everything our team has accomplished together and we are committed to making a difference for patients. #BIGAxis
We just announced that mRNA-1273, our COVID-19 vaccine candidate, has met its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study.
Read more: https://t.co/vYWEy8CKCv
BREAKING NEWS:
The 2020 #NobelPrize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing.”
“My wish is that this will provide a positive message to the young girls who would like to follow the path of science, and to show them that women in science can also have an impact through the research that they are performing.”
- 2020 Chemistry Laureate Emmanuelle Charpentier.
The amazing @VirusesImmunity made me an offer I couldn't refuse: to chart out the immune response to the coronavirus... and use the logic to understand why certain treatments work better at certain times.
My latest for @nytimes
https://t.co/4bKb7cb9Gk
For the first time in history, the Hepatitis C virus can now be cured. The 2020 Medicine Laureates’ discoveries revealed the cause of the remaining cases of chronic hepatitis and made possible blood tests and new medicines that have saved millions of lives.
#NobelPrize